Ozempic Is Making People Buy Less Food, Walmart Says
- Retailer is analyzing shopping behavior of people on drug
- Prescriptions for GLP-1s, like Ozempic, are boosting sales
This article is for subscribers only.
Walmart Inc. says it’s already seeing an impact on food-shopping demand from people taking the diabetes drug Ozempic, Wegovy and other appetite-suppressing medications.
“We definitely do see a slight change compared to the total population, we do see a slight pullback in overall basket,” John Furner, the chief executive officer of Walmart’s sprawling US operation, said in an interview Wednesday. “Just less units, slightly less calories.”